Cargando…
Therapeutic Strategies in Pulmonary Hypertension
Pulmonary hypertension (PH) is a life-threatening condition characterized by elevated pulmonary arterial pressure. It is clinically classified into five groups: patients in the first group are considered to have pulmonary arterial hypertension (PAH) whereas patients of the other groups have PH that...
Autores principales: | Fuso, Leonello, Baldi, Fabiana, Perna, Alessandra Di |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Research Foundation
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3108478/ https://www.ncbi.nlm.nih.gov/pubmed/21687513 http://dx.doi.org/10.3389/fphar.2011.00021 |
Ejemplares similares
-
Optimal management of pulmonary arterial hypertension: prognostic indicators to determine treatment course
por: Baldi, Fabiana, et al.
Publicado: (2014) -
Epigenetic Regulation and Its Therapeutic Potential in Pulmonary Hypertension
por: Wang, Yu, et al.
Publicado: (2018) -
Breathomics for Assessing the Effects of Treatment and Withdrawal With Inhaled Beclomethasone/Formoterol in Patients With COPD
por: Montuschi, Paolo, et al.
Publicado: (2018) -
Role of heparanase in pulmonary hypertension
por: Wang, Lin-Jun, et al.
Publicado: (2023) -
Targeting Chitinase 1 and Chitinase 3-Like 1 as Novel Therapeutic Strategy of Pulmonary Fibrosis
por: Lee, Suh-Young, et al.
Publicado: (2022)